U3O8 Corp is pleased to outline how the offer of a C$1 million line of credit by the Company’s founder and director, Dr. Keith Barron, in addition to funds recently raised by the Company, will be used to undertake proof-of-concept work on its Laguna Salada uranium-vanadium deposit in Argentina. The funds allow the Company to do specific test work that, if successful, is likely to significantly improve the economics of Laguna Salada by lowering operating and capital costs from those determined in the positive preliminary economic assessment (“PEA”) undertaken in 2014.

U3O8 Corp announces that it intends to proceed with a non-brokered private placement to raise up to one million Canadian Dollars (“C$) in gross proceeds through the sale of approximately 3 million units with each unit (“Unit”) consisting of a share and a warrant.

Toronto, Ontario – September 11th, 2017 – U3O8 Corp. (TSX: UWE), (OTCQB: UWEFF) (“U3O8 Corp.” or the “Company”) reports that its consolidated common shares will start trading at the open of the TSX and OTCQB markets on Monday September 11th, and that one of the Company’s directors has exercised out-of-the-money warrants to contribute working capital to the Corporation.

Toronto, Ontario – August 03, 2017 – U3O8 Corp. (TSX: UWE), (OTCQB: UWEFF) (“U3O8 Corp.” or the “Company”) is pleased to provide an update on activities since its Annual and Special Meeting (“ASM”) held on June 22, 2017, that includes: The closing of the Existing Shareholder Prospectus Exemption (“ESPE”) financing announced on June 27, 2017; Next steps in the stock consolidation that was approved by shareholders at the Company’s recent ASM; Update on metallurgical test work that has been concluded in Australia; and A note on the recent surge in vanadium prices.

Toronto, Ontario – June 23, 2017 – U3O8 Corp. (TSX: UWE), (OTCQB: UWEFF) (“U3O8 Corp.” or the “Company”) reports that all matters brought before its shareholders were approved at the Annual & Special Meeting (“ASM”) held yesterday in Toronto, Ontario. A total of 121,790,106 of the Corporation’s common shares were voted, representing 35% of its issued and outstanding stock. In addition, 19.3 million warrants expired and 2.85 million warrants were exercised for gross proceeds of $99,750, which together reduce the number of outstanding warrants by approximately 18%.